Podarcis wall lizards are endemic to the Mediterranean Basin the place they symbolize the predominant reptile group. Despite being extensively used as mannequin organisms in evolutionary and ecological research their phylogeny and historic biogeography are nonetheless incompletely resolved. Moreover, molecular clock calibrations utilized in wall lizard phylogeography are primarily based on the idea of vicariant speciation triggered by the abrupt Mediterranean Sea stage rise on the finish of the Messinian salinity disaster (MSC). However, the validity of this biogeographic calibration stays untested.
In this research we inferred a sturdy time tree primarily based on multilocus information and fossil calibrations utilizing each gene concatenation and species-tree approaches and together with models with gene-flow. We discovered 5 deeply divergent, geographically coherent, and well-supported clades comprising species from i) Iberian Peninsula and North Africa; ii) Western Mediterranean islands, iii) Sicilian and Maltese islands; and iv-v) Balkan area and Aegean islands. The mitochondrial tree exhibits some inconsistencies with the species tree that warrant future investigation. Diversification of foremost clades is estimated in a brief time body in the course of the Middle Miocene and may need been related to a interval of international local weather cooling with the institution of a marked climatic zonation in Europe.
Cladogenetic occasions inside the principle clades are scattered all through the time tree, from the Late Miocene to the Early Pleistocene, suggesting that speciation occasions in wall lizards replicate a fancy interaction between areaal topography, local weather and geological historical past reasonably than a shared main climatic or paleogeographic occasion. Our absolute time estimates, in addition to a relative courting strategy, show that the idea of a causal hyperlink between sea-level rise on the finish of the MSC and the diversification of many island endemics isn’t justified. This research reinforces the notion that a number of dispersal and vicariant occasions, at totally different time frames, are required to elucidate present allopatric distributions and to account for the historic meeting of Mediterranean biota, and cautions in opposition to the use of biogeographic calibrations primarily based on the idea of vicariance.
The 30 October 2020 Aegean Sea Tsunami: Post-Event Field Survey Along Turkish Coast
On 30 October 2020, a powerful normal-faulting earthquake struck Samos Island in Greece and İzmir Province in Turkey, each within the japanese Aegean Sea. The earthquake generated a tsunami that hit the coasts of Samos Island, Greece and İzmir, Turkey. National groups carried out two post-tsunami discipline surveys on 31 October to 1 November 2020, and 4-6 November 2020, alongside the Turkish shoreline; whereas the previous was a fast survey on the times following the tsunami, the latter concerned extra detailed measurement and investigation specializing in a ~ 110-km-long shoreline extending from Alaçatı (Çeşme District of İzmir) to Gümüldür (Menderes District of İzmir). The survey groups measured runup and tsunami heights, circulate depths, and inundation distances at greater than 120 factors at eight totally different localities.
The largest tsunami runup among the many surveyed areas was measured as 3.eight m in Akarca at a distance of 91 m from the shoreline. The most tsunami peak of 2.Three m (with a circulate depth of 1.Four m) was noticed at Kaleiçi area in Sığacık, the place probably the most extreme tsunami harm was noticed. There, the utmost runup peak was measured as 1.9 m on the northeastern facet of the bay. The survey workforce additionally investigated tsunami harm to coastal constructions, noticing a gradual lower within the affect from Gümüldür to additional southeast.
The findings of this discipline survey present insights into the coastal affect of native tsunamis within the Aegean Sea. Elucidating the genetic variation and construction of Lemnos and Lesvos sheep is vital for sustaining native genetic variety, ecosystem integrity and resilience of native meals manufacturing of the 2 North Aegean islands. In the current research, we explored genetic variety and differentiation in addition to inhabitants construction of the Lemnos and Lesvos sheep. Furthermore, we sought to determine a small panel of markers with the very best discriminatory energy to assign animals throughout islands.
Greece and Turkey Shaken by African tectonic retreat
Earthquakes are a consequence of the motions of the planet’s tectonic plates, but predicting when and the place they could happen, and learn how to put together stay some of the shortcomings of utilizing scientific data to guard human life. A devastating Mw 7.zero earthquake on October 30, 2020, offshore Samos Island, Greece was a consequence of the Aegean and Anatolian higher crust being pulled aside by north-south extensional stresses ensuing from slab rollback, the place the African plate is subducting northwards beneath Eurasia, whereas the slab is sinking by gravitational forces, inflicting it to retreat southwards.
Since the retreating African slab is coupled with the overriding plate, it tears the higher plate aside because it retreats, breaking it into quite a few small plates with frequent earthquakes alongside their boundaries. Historical earthquake swarms and deformation of the higher plate within the Aegean have been related to huge volcanism and cataclysmic devastation, such because the Mw 7.7 Amorgos earthquake in July 1956 between the islands of Naxos and Santorini (Thera).
Feline Leukemia virus p27 antibody |
|||
10-F05A | Fitzgerald | 250 ug | 369.6 EUR |
Description: Mouse monoclonal Feline Leukemia virus antibody |
|||
Feline Leukemia Virus p27 antibody |
|||
10-F05C | Fitzgerald | 250 ug | 260.4 EUR |
Description: Mouse monoclonal Feline Leukemia Virus p27 antibody |
|||
Feline Leukemia Virus gp70 antibody |
|||
10-F07A | Fitzgerald | 250 ug | 392.4 EUR |
Description: Mouse monoclonal Feline Leukemia Virus gp70 antibody |
|||
Feline Leukemia Virus gp70 antibody |
|||
10-F07B | Fitzgerald | 250 ug | 392.4 EUR |
Description: Mouse monoclonal Feline Leukemia Virus gp70 antibody |
|||
Feline leukemia virus PCR kit |
|||
PCR-V176-48R | Bioingentech | 50T | 987.6 EUR |
Feline leukemia virus PCR kit |
|||
PCR-V176-96R | Bioingentech | 100T | 1335.6 EUR |
Recombinant Bourbon virus envelope glycoprotein [His] |
|||
DAGA-3104 | Creative Diagnostics | 100ug | 1326 EUR |
Feline Leukemia Virus p27 antibody (HRP) |
|||
60-5006 | Fitzgerald | 1 ml | 490.8 EUR |
Description: Goat polyclonal Feline Leukemia Virus p27 antibody (HRP) |
|||
Feline Leukemia Virus p27 antibody (biotin) |
|||
60-5007 | Fitzgerald | 1 ml | 453.6 EUR |
Description: Goat polyclonal Feline Leukemia Virus p27 antibody (biotin) |
|||
Feline leukemia virus RT PCR kit |
|||
RTq-V176-100R | Bioingentech | 100T | 1573.2 EUR |
Feline leukemia virus RT PCR kit |
|||
RTq-V176-150R | Bioingentech | 150T | 2144.4 EUR |
Feline leukemia virus RT PCR kit |
|||
RTq-V176-50R | Bioingentech | 50T | 1155.6 EUR |
Goat polyclonal antibody for Feline Leukemia virus |
|||
7221 | Virostat | 1 ml | 340.57 EUR |
Description: This is goat polyclonal antibody against Feline Leukemia virus p27 for WB, ELISA. |
|||
Goat polyclonal antibody for Feline Leukemia virus |
|||
7223 | Virostat | 1 ml | 360.16 EUR |
Description: This is FITC conjugated goat polyclonal antibody against Feline Leukemia virus p27 for WB, ELISA. |
|||
Goat polyclonal antibody for Feline Leukemia virus |
|||
7227 | Virostat | 1 ml | 360.16 EUR |
Description: This is Biotin conjugated goat polyclonal antibody against Feline Leukemia virus p27 for WB, ELISA. |
|||
Goat polyclonal antibody for Feline Leukemia virus |
|||
274 | Virostat | 1 ml | 386.26 EUR |
Description: This is HRP conjugated goat polyclonal antibody against Feline Leukemia virus p27 for WB, ELISA. |
|||
Feline leukemia virus One-Step PCR kit |
|||
Oneq-V176-100R | Bioingentech | 100T | 1932 EUR |
Feline leukemia virus One-Step PCR kit |
|||
Oneq-V176-150R | Bioingentech | 150T | 2646 EUR |
Feline leukemia virus One-Step PCR kit |
|||
Oneq-V176-50R | Bioingentech | 50T | 1410 EUR |
Borna disease virus Envelope glycoprotein p57 (G) |
|||
1-CSB-CF345219BIN | Cusabio |
|
|
Description: Recombinant Borna disease virus Envelope glycoprotein p57(G),partial expressed in in vitro E.coli expression system |
|||
Varicella-zoster virus Envelope glycoprotein E (gE) |
|||
1-CSB-CF362630VAP | Cusabio |
|
|
Description: Recombinant Varicella-zoster virus Envelope glycoprotein E(gE) expressed in in vitro E.coli expression system |
|||
Epstein-Barr virus Envelope glycoprotein B (gB) |
|||
1-CSB-EP355975EFA | Cusabio |
|
|
Description: Recombinant Epstein-Barr virus Envelope glycoprotein B(gB),partial expressed in E.coli |
|||
Epstein-Barr virus Envelope glycoprotein L (gL) |
|||
1-CSB-EP355982EFA | Cusabio |
|
|
Description: Recombinant Epstein-Barr virus Envelope glycoprotein L(gL) expressed in E.coli |
|||
Epstein-Barr virus Envelope glycoprotein GP350 (BLLF1) |
|||
1-CSB-EP360986EFA | Cusabio |
|
|
Description: Recombinant Epstein-Barr virus Envelope glycoprotein GP350(BLLF1),partial expressed in E.coli |
|||
Epstein-Barr virus Envelope glycoprotein H (gH) |
|||
1-CSB-EP365883EFA | Cusabio |
|
|
Description: Recombinant Epstein-Barr virus Envelope glycoprotein H(gH),partial expressed in E.coli |
|||
Feline Immunodeficiency Virus gp95 Envelope Antigen (FIV gp95) Antibody |
|||
abx414342-025mg | Abbexa | 0.25 mg | 710.4 EUR |
Feline Immunodeficiency Virus gp95 Envelope Antigen (FIV gp95) Antibody |
|||
abx411335-02mg | Abbexa | 0.2 mg | 710.4 EUR |
Mouse Anti-Feline Leukemia Virus (FeLV) monoclonal antibody |
|||
CABT-BL8814 | Creative Diagnostics | 1.0 mg | 1070.4 EUR |
Mouse Anti-Feline Leukemia Virus (FeLV) monoclonal antibody |
|||
CABT-BL8815 | Creative Diagnostics | 1.0 mg | 1070.4 EUR |
Mouse antibody for Feline Leukemia virus FeLv gp70 |
|||
7217 | Virostat | 100 ug | 386.26 EUR |
Description: This is purified Mouse monoclonal antibody against Feline Leukemia virus FeLv gp70 for WB, ELISA. |
|||
Mouse antibody for Feline Leukemia virus FeLv p27 |
|||
7218 | Virostat | 100 ug | 386.26 EUR |
Description: This is purified Mouse monoclonal antibody against Feline Leukemia virus FeLv p27 for WB, ELISA. |
|||
Mouse antibody for Feline Leukemia virus FeLv p27 |
|||
7226 | Virostat | 100 ug | 386.26 EUR |
Description: This is purified Mouse monoclonal antibody against Feline Leukemia virus FeLv p27 for WB, ELISA. |
|||
Mouse antibody for Feline Leukemia virus FeLv p27 |
|||
7228 | Virostat | 100 ug | 386.26 EUR |
Description: This is purified Mouse monoclonal antibody against Feline Leukemia virus FeLv p27 for WB, ELISA. |
|||
Bovine Leukemia Virus(Leukemia Virus) |
|||
QY-E60121 | Qayee Biotechnology | 96T | 511.2 EUR |
Recombinant Zika Virus Envelope protein |
|||
DAGA-048 | Creative Diagnostics | 100 µg | 774 EUR |
Recombinant Zika Virus Envelope protein |
|||
DAGA6128 | Creative Diagnostics | 2UG | 624 EUR |
Recombinant West Nile Envelope Virus |
|||
7-07960 | CHI Scientific | 100µg | Ask for price |
Recombinant West Nile Envelope Virus |
|||
7-07961 | CHI Scientific | 500µg | Ask for price |
Recombinant West Nile Envelope Virus |
|||
7-07962 | CHI Scientific | 1000µg | Ask for price |
Zika virus Envelope recombinant antigen |
|||
8826 | Virostat | 100 ug | 673.36 EUR |
Description: This is Zika virus Envelope recombinant antigen for ELISA,WB. |
|||
Recombinant Japanese Encephalitis Virus Envelope |
|||
P1112-10 | Biovision | 157.2 EUR | |
Recombinant Japanese Encephalitis Virus Envelope |
|||
P1112-50 | Biovision | 366 EUR | |
West Nile Virus Envelope Recombinant Protein |
|||
53-361 | ProSci | 0.01 mg | 714.3 EUR |
Description: West Nile Virus Envelope Recombinant Protein |
|||
West Nile Virus Envelope recombinant antigen |
|||
00401-V-01mg | Virogen | 0,1 mg | 321 EUR |
Description: West Nile Virus Envelope recombinant antigen-Immunodominant region |
|||
West Nile Virus Envelope recombinant antigen |
|||
00401-V-1000ug | Virogen | 1000 ug | 1539 EUR |
Description: West Nile Virus Envelope recombinant antigen-Immunodominant region |
|||
West Nile Virus Envelope recombinant antigen |
|||
8822 | Virostat | 100 ug | 529.8 EUR |
Description: This is West Nile Virus Envelope recombinant antigen for ELISA,WB. |
|||
Recombinant West Nile Virus Envelope Protein |
|||
P1065-10 | Biovision | 189.6 EUR | |
Recombinant West Nile Virus Envelope Protein |
|||
P1065-50 | Biovision | 366 EUR | |
Zika virus envelope protein |
|||
30-1932 | Fitzgerald | 100 ug | 457.2 EUR |
Description: Recombinant Zika virus envelope protein |
|||
Zika virus envelope protein |
|||
30-1935 | Fitzgerald | 100 ug | 289.2 EUR |
Description: Recombinant Zika virus envelope protein |
|||
Zika virus envelope antibody |
|||
10-2712 | Fitzgerald | 1 mg | 678 EUR |
Description: Mouse monoclonal Zika virus envelope antibody |
|||
Zika virus envelope antibody |
|||
10-2713 | Fitzgerald | 1 mg | 678 EUR |
Description: Mouse monoclonal Zika virus envelope antibody |
|||
Zika virus envelope antibody |
|||
10-2714 | Fitzgerald | 1 mg | 678 EUR |
Description: Mouse monoclonal Zika virus envelope antibody |
|||
Zika virus envelope antibody |
|||
10-2715 | Fitzgerald | 1 mg | 678 EUR |
Description: Mouse monoclonal Zika virus envelope antibody |
|||
Zika Virus Envelope Protein |
|||
abx160022-1mg | Abbexa | 1 mg | 1746 EUR |
Zika Virus Envelope Protein |
|||
abx061381-1mg | Abbexa | 1 mg | 1722 EUR |
Chikungunya Virus Envelope Antibody |
|||
abx024072-1mg | Abbexa | 1 mg | 1161.6 EUR |
Chikungunya Virus Envelope Antibody |
|||
abx024073-1mg | Abbexa | 1 mg | 1161.6 EUR |
Chikungunya Virus Envelope Antibody |
|||
abx024074-1mg | Abbexa | 1 mg | 1161.6 EUR |
Chikungunya Virus Envelope Antibody |
|||
abx024075-1mg | Abbexa | 1 mg | 1161.6 EUR |
Chikungunya Virus Envelope Antibody |
|||
abx024076-1mg | Abbexa | 1 mg | 1161.6 EUR |
Zika Virus Envelope Antibody |
|||
abx024128-1mg | Abbexa | 1 mg | 1730.4 EUR |
Zika Virus Envelope Antibody |
|||
abx024129-1mg | Abbexa | 1 mg | 1730.4 EUR |
Zika Virus Envelope Antibody |
|||
abx024130-1mg | Abbexa | 1 mg | 1730.4 EUR |
Zika Virus Envelope Antibody |
|||
abx024131-1mg | Abbexa | 1 mg | 1730.4 EUR |
Zika Virus Envelope Antibody |
|||
abx024132-1mg | Abbexa | 1 mg | 1696.8 EUR |
Zika Virus Envelope Antibody |
|||
abx024133-1mg | Abbexa | 1 mg | 1696.8 EUR |
Recombinant Feline Immunodeficiency Virus Core Antigen |
|||
DAG552 | Creative Diagnostics | 100ug | 1138.8 EUR |
Feline Immunodeficiency virus core Recombinant Protein |
|||
53-312 | ProSci | 0.01 mg | 852.9 EUR |
Description: Feline Immunodeficiency virus core Recombinant Protein |
|||
Feline Immunodef. virus core recombinant antigen |
|||
8963 | Virostat | 100 ug | 673.36 EUR |
Description: This is Feline Immunodef. virus core recombinant antigen for ELISA,WB. |
|||
Mouse Anti Epstein-Barr Virus Envelope Glycoprotein Complex Monoclonal Antibody |
|||
DMABT-51230ME | Creative Diagnostics | 0.1 mg | 1070.4 EUR |
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody |
|||
abx411417-1ml | Abbexa | 1 ml | 610.8 EUR |
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody |
|||
abx412175-1mg | Abbexa | 1 mg | 610.8 EUR |
Feline Leukemia Virus Subgroup C Receptor-Related Protein 2 (FLVCR2) Antibody |
|||
20-abx006544 | Abbexa |
|
|
Feline Leukemia Virus Subgroup C Receptor-Related Protein 2 (FLVC2) Antibody |
|||
abx034469-400ul | Abbexa | 400 ul | 627.6 EUR |
Feline Leukemia Virus Subgroup C Receptor-Related Protein 2 (FLVC2) Antibody |
|||
abx034469-80l | Abbexa | 80 µl | 343.2 EUR |
Feline Leukemia Virus Subgroup C Receptor-Related Protein 2 (FLVCR2) Antibody |
|||
20-abx322439 | Abbexa |
|
|
Feline Leukemia Virus Subgroup C Receptor-Related Protein 2 (FLVCR2) Antibody |
|||
20-abx322440 | Abbexa |
|
|
Human CellExp? Recombinant EBOV Envelope Glycoprotein 1 |
|||
P1060-10 | Biovision | 170.4 EUR | |
Human CellExp? Recombinant EBOV Envelope Glycoprotein 1 |
|||
P1060-50 | Biovision | 483.6 EUR | |
Recombinant EBOV Envelope Glycoprotein (aa 33-637) |
|||
VAng-0669Lsx-100g | Creative Biolabs | 100 µg | 1017.6 EUR |
Description: Ebola virus BDBV (subtype Zaire strain Kikwit-95) Envelope Glycoprotein (GP) containing GP1 and GP2, recombinant protein from HEK 293 cells with a polyhistidine tag at the C-terminus. |
|||
Recombinant EBOV Envelope Glycoprotein (aa 33-637) |
|||
VAng-0669Lsx-1mg | Creative Biolabs | 1 mg | 5998.8 EUR |
Description: Ebola virus BDBV (subtype Zaire strain Kikwit-95) Envelope Glycoprotein (GP) containing GP1 and GP2, recombinant protein from HEK 293 cells with a polyhistidine tag at the C-terminus. |
|||
Recombinant Dengue Virus Subtype-1 Envelope 22kDa |
|||
7-07966 | CHI Scientific | 100µg | Ask for price |
Recombinant Dengue Virus Subtype-1 Envelope 22kDa |
|||
7-07967 | CHI Scientific | 500µg | Ask for price |
Recombinant Dengue Virus Subtype-1 Envelope 22kDa |
|||
7-07968 | CHI Scientific | 1000µg | Ask for price |
Recombinant Dengue Virus Subtype-2 Envelope 22kDa |
|||
7-07969 | CHI Scientific | 100µg | Ask for price |
Recombinant Dengue Virus Subtype-2 Envelope 22kDa |
|||
7-07970 | CHI Scientific | 500µg | Ask for price |
Recombinant Dengue Virus Subtype-2 Envelope 22kDa |
|||
7-07971 | CHI Scientific | 1000µg | Ask for price |
Recombinant Dengue Virus Subtype-3 Envelope 22kDa |
|||
7-07972 | CHI Scientific | 100µg | Ask for price |
Recombinant Dengue Virus Subtype-3 Envelope 22kDa |
|||
7-07973 | CHI Scientific | 500µg | Ask for price |
Recombinant Dengue Virus Subtype-3 Envelope 22kDa |
|||
7-07974 | CHI Scientific | 1000µg | Ask for price |
Recombinant Dengue Virus Subtype-4 Envelope 22kDa |
|||
7-07975 | CHI Scientific | 100µg | Ask for price |
Recombinant Dengue Virus Subtype-4 Envelope 22kDa |
|||
7-07976 | CHI Scientific | 500µg | Ask for price |
Recombinant Dengue Virus Subtype-4 Envelope 22kDa |
|||
7-07977 | CHI Scientific | 1000µg | Ask for price |
Sudan ebolavirus Envelope glycoprotein (GP) |
|||
1-CSB-MP742487SRE | Cusabio |
|
|
Description: Recombinant Sudan ebolavirus Envelope glycoprotein (GP) ,partial expressed in Mammalian cell |
|||
Zaire ebolavirus Envelope glycoprotein (GP) |
|||
1-CSB-YP310843ZAA | Cusabio |
|
|
Description: Recombinant Zaire ebolavirus Envelope glycoprotein(GP),partial expressed in Yeast |
|||
Sudan ebolavirus Envelope glycoprotein (GP) |
|||
1-CSB-YP742487SRE | Cusabio |
|
|
Description: Recombinant Sudan ebolavirus Envelope glycoprotein(GP),partial expressed in Yeast |
|||
Zaire ebolavirus Envelope glycoprotein (GP) |
|||
1-CSB-EP311249ZAT | Cusabio |
|
|
Description: Recombinant Zaire ebolavirus Envelope glycoprotein(GP),partial expressed in E.coli |
|||
Cytomegalovirus Envelope Glycoprotein H Antibody |
|||
20-abx109273 | Abbexa |
|
|
Cytomegalovirus Envelope Glycoprotein L Antibody |
|||
20-abx109402 | Abbexa |
|
|
Herpesvirus Envelope glycoprotein D Antibody |
|||
20-abx109865 | Abbexa |
|
|
Envelope Glycoprotein GP350 (BLLF1) Antibody |
|||
20-abx319925 | Abbexa |
|
|
Envelope glycoprotein B (GB) Antibody |
|||
20-abx317791 | Abbexa |
|
|
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody (Biotin) |
|||
abx411418-1ml | Abbexa | 1 ml | 710.4 EUR |
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody (HRP) |
|||
abx411419-1ml | Abbexa | 1 ml | 760.8 EUR |
West Nile Virus Envelope Antibody |
|||
24282-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Envelope Antibody |
|||
24283-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Envelope Antibody |
|||
24284-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Envelope Antibody |
|||
3437-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3437-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Peptide |
|||
3437P | ProSci | 0.05 mg | 197.7 EUR |
Description: (IN) West Nile Virus Envelope peptide |
|||
West Nile Virus Envelope Antibody |
|||
3439-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3439-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Peptide |
|||
3439P | ProSci | 0.05 mg | 197.7 EUR |
Description: (NT) West Nile Virus Envelope peptide |
|||
West Nile Virus Envelope Antibody |
|||
3441-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3441-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Peptide |
|||
3441P | ProSci | 0.05 mg | 197.7 EUR |
Description: (IN) West Nile Virus Envelope peptide |
|||
West Nile Virus Envelope Protein |
|||
abx060680-100ug | Abbexa | 100 ug | 794.4 EUR |
Dengue Virus (Pan) Envelope Antibody |
|||
abx024077-1mg | Abbexa | 1 mg | 1062 EUR |
West Nile Envelope Virus Protein |
|||
20-abx260322 | Abbexa |
|
|
Dengue Virus Envelope 2 Protein |
|||
20-abx261884 | Abbexa |
|
|
Moloney Leukemia Virus Reverse Trancscriptase (Recombinant) |
|||
abx073903-10000U | Abbexa | 10.000 U | 393.6 EUR |
Moloney Leukemia Virus Reverse Trancscriptase (Recombinant) |
|||
abx073903-2500U | Abbexa | 2.500 U | 276 EUR |
Moloney Leukemia Virus Reverse Trancscriptase (Recombinant) |
|||
abx073903-50000U | Abbexa | 50.000 U | 1062 EUR |
Recombinant Myeloproliferative Leukemia Virus Oncogene (MPL) |
|||
4-RPB468Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Myeloproliferative Leukemia Virus Oncogene expressed in: E.coli |
|||
Recombinant Myeloproliferative Leukemia Virus Oncogene (MPL) |
|||
4-RPB468Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Myeloproliferative Leukemia Virus Oncogene expressed in: E.coli |
|||
Feline Panleukopenia Virus PCR kit |
|||
PCR-V171-48D | Bioingentech | 50T | 543.6 EUR |
Feline Panleukopenia Virus PCR kit |
|||
PCR-V171-96D | Bioingentech | 100T | 686.4 EUR |
Feline immunodeficiency virus PCR kit |
|||
PCR-V175-48R | Bioingentech | 50T | 987.6 EUR |
Feline immunodeficiency virus PCR kit |
|||
PCR-V175-96R | Bioingentech | 100T | 1335.6 EUR |
Mouse Leukemia virus protein |
|||
30-1273 | Fitzgerald | 1 mg | 289.2 EUR |
Description: Purified native Mouse Leukemia virus protein |
|||
Rabies Virus Glycoprotein |
|||
HY-P0285 | MedChemExpress | 1mg | 308.4 EUR |
Recombinant Cytomegalovirus Envelope glycoprotein 1, His, Yeast-100ug |
|||
QP7456-ye-100ug | EnQuireBio | 100ug | 979.2 EUR |
Recombinant Cytomegalovirus Envelope glycoprotein 1, His, Yeast-10ug |
|||
QP7456-ye-10ug | EnQuireBio | 10ug | 445.2 EUR |
Recombinant Cytomegalovirus Envelope glycoprotein 1, His, Yeast-1mg |
|||
QP7456-ye-1mg | EnQuireBio | 1mg | 3296.4 EUR |
Recombinant Cytomegalovirus Envelope glycoprotein 1, His, Yeast-200ug |
|||
QP7456-ye-200ug | EnQuireBio | 200ug | 1555.2 EUR |
Recombinant Cytomegalovirus Envelope glycoprotein 1, His, Yeast-500ug |
|||
QP7456-ye-500ug | EnQuireBio | 500ug | 2164.8 EUR |
Recombinant Cytomegalovirus Envelope glycoprotein 1, His, Yeast-50ug |
|||
QP7456-ye-50ug | EnQuireBio | 50ug | 598.8 EUR |
Recombinant Human Immunodeficiency Virus Type 2 Envelope, Gp36 |
|||
DAG523 | Creative Diagnostics | 1mg | 1340.4 EUR |
Human cytomegalovirus Envelope glycoprotein H (gH) |
|||
1-CSB-YP319015HWV | Cusabio |
|
|
Description: Recombinant Human cytomegalovirus Envelope glycoprotein H(gH),partial expressed in Yeast |
|||
Human cytomegalovirus Envelope glycoprotein L (gL) |
|||
1-CSB-YP515269HWW | Cusabio |
|
|
Description: Recombinant Human cytomegalovirus Envelope glycoprotein L(gL) expressed in Yeast |
|||
Lake Victoria marburgvirus Envelope glycoprotein (GP) |
|||
1-CSB-BP330440LBR | Cusabio |
|
|
Description: Recombinant Lake Victoria marburgvirus Envelope glycoprotein(GP),partial expressed in Baculovirus |
|||
Rhesus cytomegalovirus Envelope glycoprotein B (gB) |
|||
1-CSB-EP309330RKC | Cusabio |
|
|
Description: Recombinant Rhesus cytomegalovirus Envelope glycoprotein B(gB),partial expressed in E.coli |
|||
Human cytomegalovirus Envelope glycoprotein H (gH) |
|||
1-CSB-EP319015HWV | Cusabio |
|
|
Description: Recombinant Human cytomegalovirus Envelope glycoprotein H(gH),partial expressed in E.coli |
|||
Lake Victoria marburgvirus Envelope glycoprotein (GP) |
|||
1-CSB-EP330440LBR | Cusabio |
|
|
Description: Recombinant Lake Victoria marburgvirus Envelope glycoprotein(GP),partial expressed in E.coli |
|||
Human cytomegalovirus Envelope glycoprotein L (gL) |
|||
1-CSB-EP515269HWW | Cusabio |
|
|
Description: Recombinant Human cytomegalovirus Envelope glycoprotein L(gL) expressed in E.coli |
|||
Cytomegalovirus Envelope Glycoprotein H Antibody (HRP) |
|||
20-abx108160 | Abbexa |
|
|
Herpesvirus Envelope glycoprotein D Antibody (HRP) |
|||
20-abx108347 | Abbexa |
|
|
Cytomegalovirus Envelope Glycoprotein L Antibody (HRP) |
|||
20-abx109036 | Abbexa |
|
|
Herpesvirus 1 Envelope glycoprotein G Antibody |
|||
20-abx109864 | Abbexa |
|
|
Cytomegalovirus Envelope Glycoprotein H Antibody (Biotin) |
|||
20-abx105322 | Abbexa |
|
|
Herpesvirus Envelope glycoprotein D Antibody (Biotin) |
|||
20-abx105508 | Abbexa |
|
|
Cytomegalovirus Envelope Glycoprotein L Antibody (Biotin) |
|||
20-abx106203 | Abbexa |
|
|
Cytomegalovirus Envelope Glycoprotein H Antibody (FITC) |
|||
20-abx106741 | Abbexa |
|
|
Herpesvirus Envelope glycoprotein D Antibody (FITC) |
|||
20-abx106925 | Abbexa |
|
|
Cytomegalovirus Envelope Glycoprotein L Antibody (FITC) |
|||
20-abx107619 | Abbexa |
|
|
Envelope glycoprotein B (GB) Antibody (HRP) |
|||
20-abx317792 | Abbexa |
|
|
Envelope glycoprotein B (GB) Antibody (FITC) |
|||
20-abx317793 | Abbexa |
|
|
Envelope glycoprotein B (GB) Antibody (Biotin) |
|||
20-abx317794 | Abbexa |
|
|
Recombinant Moloney Mouse Leukemia Virus Reverse Trancscriptase |
|||
7-03139 | CHI Scientific | 2,500U | Ask for price |
Recombinant Moloney Mouse Leukemia Virus Reverse Trancscriptase |
|||
7-03140 | CHI Scientific | 10,000U | Ask for price |
Recombinant Moloney Mouse Leukemia Virus Reverse Trancscriptase |
|||
7-03141 | CHI Scientific | 50,000U | Ask for price |
Recombinant Friend Leukemia Virus Integration 1 (FLI1) |
|||
4-RPC492Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Friend Leukemia Virus Integration 1 expressed in: E.coli |
Even extra notable was the eruption of Santorini 3650 years in the past, which contributed to the autumn of the Minoan civilization. The Samos earthquake highlights the lengthy historic lack of appreciation of hyperlinks between deep tectonic processes and higher crustal deformation and geological hazards, and is a harbinger of future earthquakes and volcanic eruptions, establishing a foundation for research to institute higher safety of infrastructure and higher plate cultures within the area.